Correlation Between China Pharma and SNDL
Can any of the company-specific risk be diversified away by investing in both China Pharma and SNDL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and SNDL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Pharma Holdings and SNDL Inc, you can compare the effects of market volatilities on China Pharma and SNDL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of SNDL. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and SNDL.
Diversification Opportunities for China Pharma and SNDL
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between China and SNDL is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and SNDL Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SNDL Inc and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with SNDL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SNDL Inc has no effect on the direction of China Pharma i.e., China Pharma and SNDL go up and down completely randomly.
Pair Corralation between China Pharma and SNDL
Given the investment horizon of 90 days China Pharma Holdings is expected to generate 2.75 times more return on investment than SNDL. However, China Pharma is 2.75 times more volatile than SNDL Inc. It trades about -0.03 of its potential returns per unit of risk. SNDL Inc is currently generating about -0.15 per unit of risk. If you would invest 20.00 in China Pharma Holdings on October 1, 2024 and sell it today you would lose (1.69) from holding China Pharma Holdings or give up 8.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
China Pharma Holdings vs. SNDL Inc
Performance |
Timeline |
China Pharma Holdings |
SNDL Inc |
China Pharma and SNDL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with China Pharma and SNDL
The main advantage of trading using opposite China Pharma and SNDL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, SNDL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SNDL will offset losses from the drop in SNDL's long position.China Pharma vs. Universe Pharmaceuticals | China Pharma vs. Sonoma Pharmaceuticals | China Pharma vs. Akanda Corp | China Pharma vs. Halo Collective |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |